Madeline Snipes
Papers
1
Total Citations
3
H-Index
1
About
Dr. Madeline Snipes is a pioneering urologic oncologist whose research is reshaping surgical approaches to upper tract urothelial carcinoma (UTUC). Her work centers on comparing open, laparoscopic, and robotic radical nephroureterectomy (RNU), with a focus on optimizing patient outcomes while controlling healthcare costs. In her landmark 2025 study, Dr. Snipes introduced and validated the "tetrafecta"—a novel composite outcome measure that captures the full spectrum of surgical success, including oncologic control, complication avoidance, and functional recovery. This framework has already garnered 3 citations and is poised to become a standard benchmark in the field. By rigorously analyzing perioperative outcomes and survival data across surgical platforms, she has provided critical evidence that robotic approaches may offer distinct advantages in select patients. Her work directly informs clinical decision-making for surgeons and trainees, bridging the gap between technical innovation and real-world patient care. Dr. Snipes’ contributions are particularly vital as UTUC management evolves toward minimally invasive techniques, making her a leading voice in the next generation of urologic oncology research.
Research Focus
Key Achievements
Top Papers
- 1